A Phase II Single-Arm Study of Therapeutic Iobenguane (131-I) for High-Risk Neuroblastoma at theTime of First Relapse

Conditions:   Neuroblastoma;   Neuroectodermal Tumors;   Neoplasms Intervention:   Drug: 131I-MIBG Sponsor:   Jubilant DraxImage Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials